World News
Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
Health & Wellness
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma treatment.
Health & Wellness
When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage clinical trial in melanoma, oncologists and the public alike were exhilarated. And that was before its makers had even disclosed just how well the therapy worked.
Health & Wellness
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.